Chu David S H, Bocek Michael J, Shi Julie, Ta Anh, Ngambenjawong Chayanon, Rostomily Robert C, Pun Suzie H
Department of Bioengineering and Molecular Engineering and Sciences Institute, University of Washington, Seattle, WA 98195, USA.
Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.
J Control Release. 2015 May 10;205:155-61. doi: 10.1016/j.jconrel.2015.01.013. Epub 2015 Jan 14.
Several cationic antimicrobial peptides have been investigated as potential anti-cancer drugs due to their demonstrated selective toxicity towards cancer cells relative to normal cells. For example, intracellular delivery of KLA, a pro-apoptotic peptide, results in toxicity against a variety of cancer cell lines; however, the relatively low activity and small size lead to rapid renal excretion when applied in vivo, limiting its therapeutic potential. In this work, apoptotic peptide-polymer hybrid materials were developed to increase apoptotic peptide activity via multivalent display. Multivalent peptide materials were prepared with comb-like structure by RAFT copolymerization of peptide macromonomers with N-(2-hydroxypropyl) methacrylamide (HPMA). Polymers displayed a GKRK peptide sequence for targeting p32, a protein often overexpressed on the surface of cancer cells, either fused with or as a comonomer to a KLA macromonomer. In three tested cancer cell lines, apoptotic polymers were significantly more cytotoxic than free peptides as evidenced by an order of magnitude decrease in IC50 values for the polymers compared to free peptide. The uptake efficiency and intracellular trafficking of one polymer construct was determined by radiolabeling and subcellular fractionation. Despite their more potent cytotoxic profile, polymeric KLA constructs have poor cellular uptake efficiency (<1%). A significant fraction (20%) of internalized constructs localize with intact mitochondrial fractions. In an effort to increase cellular uptake, polymer amines were converted to guanidines by reaction with O-methylisourea. Guanidinylated polymers disrupted function of isolated mitochondria more than their lysine-based analogs, but overall toxicity was decreased, likely due to inefficient mitochondrial trafficking. Thus, while multivalent KLA polymers are more potent than KLA peptides, these materials can be substantially improved by designing next generation materials with improved cellular internalization and mitochondrial targeting efficiency.
几种阳离子抗菌肽已被作为潜在的抗癌药物进行研究,因为它们已证明相对于正常细胞对癌细胞具有选择性毒性。例如,促凋亡肽KLA的细胞内递送会导致对多种癌细胞系产生毒性;然而,其相对较低的活性和较小的尺寸导致在体内应用时会迅速经肾脏排泄,限制了其治疗潜力。在这项工作中,开发了凋亡肽 - 聚合物杂化材料,通过多价展示来提高凋亡肽的活性。通过肽大分子单体与N -(2 - 羟丙基)甲基丙烯酰胺(HPMA)的可逆加成 - 断裂链转移(RAFT)共聚制备了具有梳状结构的多价肽材料。聚合物展示了用于靶向p32的GKRK肽序列,p32是一种常在癌细胞表面过度表达的蛋白质,它与KLA大分子单体融合或作为共聚单体。在三种测试的癌细胞系中,凋亡聚合物的细胞毒性明显高于游离肽,聚合物的半数抑制浓度(IC50)值与游离肽相比降低了一个数量级就证明了这一点。通过放射性标记和亚细胞分级分离确定了一种聚合物构建体的摄取效率和细胞内运输。尽管聚合物KLA构建体具有更强的细胞毒性,但细胞摄取效率较差(<1%)。内化构建体的很大一部分(20%)定位于完整的线粒体部分。为了提高细胞摄取,通过与O - 甲基异脲反应将聚合物胺转化为胍。胍基化聚合物比基于赖氨酸的类似物更能破坏分离线粒体的功能,但总体毒性降低了,这可能是由于线粒体运输效率低下。因此,虽然多价KLA聚合物比KLA肽更有效,但通过设计具有改善的细胞内化和线粒体靶向效率的下一代材料,这些材料可以得到实质性改进。